Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Hydreight Technologies Inc ( (TSE:NURS) ) has provided an announcement.
Hydreight Technologies Inc. has been recognized for its rapid growth and innovation, ranking #25 on Deloitte’s 2025 Technology Fast 50 in Canada. The company reported significant expansion in its nurse network and pharmacy orders, alongside a strong financial position with CA$18.7 million in cash. Hydreight is advancing its infrastructure with the integration of pharmacy partners and the upcoming release of VSDHOne V2, enhancing its telehealth platform’s automation and scalability. These developments position Hydreight for accelerated growth in its GLP-1, direct-to-consumer, and pharmacy network initiatives, while actively exploring mergers and acquisitions to expand its national presence.
The most recent analyst rating on (TSE:NURS) stock is a Buy with a C$8.50 price target. To see the full list of analyst forecasts on Hydreight Technologies Inc stock, see the TSE:NURS Stock Forecast page.
More about Hydreight Technologies Inc
Hydreight Technologies Inc. operates in the digital healthcare industry, providing a compliant telehealth and medical network across the United States. The company connects healthcare providers, pharmacies, and patients through its proprietary VSDHOne platform, offering services in GLP-1 weight-management, hormone therapy, and more.
Average Trading Volume: 181,418
Technical Sentiment Signal: Buy
Current Market Cap: C$115M
Find detailed analytics on NURS stock on TipRanks’ Stock Analysis page.